Offer - Urjas Oil for just ₹ 1 X
Rivamer 1.5 Mg Capsule, a prescription drug, is manufactured in various forms such as Capsule. Alzheimer's Disease, Parkinson's Disease are some of its major therapeutic uses. Rivamer 1.5 Mg Capsule also has some secondary and off-label uses. These are listed below.
Medical history of the patient along with age and gender determines the dosage of Rivamer 1.5 Mg Capsule. The condition it has been prescribed for, and the route of administration also determine the right dosage. Refer to the dosage section for a detailed discussion.
The most common side effects of Rivamer 1.5 Mg Capsule are Fainting, Indigestion. Apart from the aforementioned side effects, Rivamer 1.5 Mg Capsule can also lead to other problems, which have been listed below. Such side effects of Rivamer 1.5 Mg Capsule normally do not last long and go away once the treatment is completed. Consult your doctor if these side effects become worse or stay for a longer duration.
Rivamer 1.5 Mg Capsule's effect during pregnancy is Safe and Mild while nursing. Further, the section on Rivamer 1.5 Mg Capsule related warnings talks about Rivamer 1.5 Mg Capsule's effects on the liver, heart and kidney.
Rivamer 1.5 Mg Capsule is contraindicated in people with pre-existing medical conditions like Kidney Disease, Asthma, COPD (Chronic Obstructive Pulmonary Disease) as it can result in adverse effects. Other conditions have been mentioned below in the Rivamer 1.5 Mg Capsule contraindications section.
Drug reaction of Rivamer 1.5 Mg Capsule with other medicines has been reported. Refer to the list below for further details.
In addition to the above precautions for Rivamer 1.5 Mg Capsule, it is important to know that it is not safe while driving, and is not habit-forming.
Rivamer 1.5 Mg Capsule is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Rivamer 1.5 Mg Capsule safe for pregnant women?
There are no side effects of Rivamer in pregnant women.
Is the use of Rivamer 1.5 Mg Capsule safe during breastfeeding?
Rivamer may have very limited harmful effects for breastfeeding women.
What is the effect of Rivamer 1.5 Mg Capsule on the Kidneys?
Rivamer rarely affects the kidneys.
What is the effect of Rivamer 1.5 Mg Capsule on the Liver?
Rivamer may have mild side effects on the liver. Most people will never see any effect on the liver.
What is the effect of Rivamer 1.5 Mg Capsule on the Heart?
Using Rivamer does not have any harmful effects on the heart.
Rivamer 1.5 Mg Capsule should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Rivamer 1.5 Mg Capsule unless your doctor advises you to do so -
Is this Rivamer 1.5 Mg Capsule habit forming or addictive?
Rivamer 1.5 Mg Capsule does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
No, you should not drive or operate heavy machinery after taking Rivamer 1.5 Mg Capsule as you may feel sleepy.
Is it safe?
Rivamer 1.5 Mg Capsule should be used only after doctor's advice.
Is it able to treat mental disorders?
Yes, in many cases, taking Rivamer 1.5 Mg Capsule can help with mental disorders.
Interaction between Food and Rivamer 1.5 Mg Capsule
It is safe to take Rivamer 1.5 Mg Capsule with food.
Interaction between Alcohol and Rivamer 1.5 Mg Capsule
Consumption of alcohol and Rivamer 1.5 Mg Capsule together may have severe effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Exelon® (rivastigmine tartrate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 108
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1110-1112